# Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

> **NCT04498767** · NA · RECRUITING · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 200 (estimated)

## Conditions studied

- Gynecologic Cancer
- Skin Cancer
- Head and Neck Cancer
- Sarcoma
- Renal Cancer
- Bladder Cancer
- Upper Urinary Tract Carcinoma
- Pancreatic Cancer
- Hepatobiliary Cancer
- Gastric Cancer
- Small Bowel Cancer
- Esophageal Cancer
- Melanoma
- Colon Cancer
- Oligometastasis

## Interventions

- **RADIATION:** Stereotactic body radiotherapy
- **RADIATION:** Palliative RT

## Key facts

- **NCT ID:** NCT04498767
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-10
- **Primary completion:** 2028-08-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-08-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04498767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04498767, "Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04498767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*